Finland's Solu Raises €1 Million, Partners With Stanford And Plans A Pathogen Dna Library To Speed Up The Identification Of Antibiotic Resistance
Amount Raised
€1 Million
Round Type
Seed
Investors
Description
Finnish biotech start-up Solu has raised €1 million in funding to fuel the development and commercialisation of its product as it plans to builds an extensive pathogen DNA library
Who else raised in Education and Biotechnology around the same time
Companies in the same sectors as Solu that raised within 45 days of this round, from Fundz verified event records.
- Béa Fertility raised $3.2M (Seed) on July 31, 2023.
- Streamex Corp. raised $2.2M (Seed) on July 31, 2023.
- FeelBetter raised $5.9M (Funding Round) on July 31, 2023.
- Aulos Bioscience, Inc. raised $5M on July 28, 2023.
- MarvelBiome raised $10M on July 28, 2023.
- Remedy Plan raised $19M on July 28, 2023.
Who to call at Solu, and when
A new round usually means Solu is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Solu raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Solu, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Solu. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Solu raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Solu raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.